Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jul 2026 and Aug 2026.
- Largest single sale: $5.1M (130,352 shares) of Edgewise Therapeutics, Inc. on Jul 1, 2026. Filing
- Last sale before this period: Aug 26, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Chief Scientific Officer, Director | Mar 25, 2021 | Aug 17, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 12, 2026, Edgewise Therapeutics, Inc.: sold 5,901 shares for $258K, to cover taxes; 12,812 shares vested. 1 filing: 1
- Jul 1, 2026, Edgewise Therapeutics, Inc.: sold 200,000 shares for $7.9M, under a disclosed plan; 200,000 shares acquired by exercising options. 1 filing: 1
- Nov 12, 2025, Edgewise Therapeutics, Inc.: sold 100,000 shares for $2.1M, no plan disclosed; 100,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.